Julian Moran, BSc Rationale and design of the PIONEER PLUS study evaluating high dose oral GLP-1 receptor agonist therapy for the treatment of type 2 diabetes
Olivia Trofimuk, BA, MA Development of Clostridioides Screening for Inflammatory Bowel Disease Patients
